- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Obesity
- Meeting Date: November 2025
- Public Summary Document (PSD) November 2025 PBAC Meeting - (PDF 1.1MB)
- Public Summary Document (PSD) November 2025 PBAC Meeting - (Word 397.8KB)
Semaglutide – November 2025
Semaglutide: Solution for injection 0.25 mg in 0.5 mL single dose pre-filled pen Solution for injection 0.5 mg in 0.5 mL single dose pre-filled pen Solution for injection 1 mg in 0.5 mL single dose pre-filled pen Solution for injection 1.7 mg in 0.75 mL single dose pre-filled pen Solution for injection 2.4mg in 0.75mL single dose pre-filled pen; Wegovy® - November 2025
Last updated
5 November 2025
